Skip to main content
ADCES25 Main banner

Diabetes Across the Lifespan and the Cardiometabolic Continuum

F24 - Advancing Detection & Treatment: Heart Failure with Preserved Ejection Fraction & Diabetes

Friday, August 8, 2025
3:30 PM - 4:15 PM MST
CE/CME Hours: .75 CE
Pharmacology Hours: .25 CE
Universal Activity Number (Live): JA4008258-0000-25-107-L01-P
Heart failure (HF) is a common complication of diabetes, affecting over 20% of patients. While the overall incidence of HF in the US has been stable, HF with preserved ejection fraction (HFpEF) is rising, in part due to the metabolic disease epidemic. Despite the prevalence of HFpEF, effective therapies for reducing morbidity and mortality have only recently been discovered. With these advancements, it is crucial to screen patients for early diagnosis and the need for therapy for HFpEF. This session will discuss how to recognize, screen, educate, and treat patients with comorbid diabetes and HFpEF. Attendees will learn the latest strategies and tools to improve patient outcomes.
Disclosure(s):
Kevin Malloy, PharmD, BCPS, BC-ADM, CDCES: Sanofi: Speaker/Honoraria (Ongoing)
Julianne Fallon, PharmD, BCCP: No financial relationships to disclose
Emily McElhaney, PharmD, BCCP: No financial relationships to disclose